The Effects of Acupressure on Improving Postoperative Gastrointestinal Symptom Distress in Esophageal Cancer Patients
1 other identifier
interventional
48
1 country
1
Brief Summary
This study is a quasi-experimental design clinical trial with the primary objective of comparing the health status of patients with esophageal cancer. Participants were divided into an experimental group and a control group. Patients in the experimental group received routine care and acupressure for 5 consecutive days starting from the day after entering the ward after esophageal cancer surgery, in the control group, participants received routine care, and Participants were assessed on the Gastrointestinal Symptom Distress Scale at the end of the intervention. The aim of this study was to verify the effectiveness of acupressure in improving of gastrointestinal symptoms distress after esophageal cancer surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 17, 2024
CompletedFirst Posted
Study publicly available on registry
February 23, 2024
CompletedStudy Start
First participant enrolled
March 27, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 18, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 18, 2025
CompletedAugust 7, 2025
August 1, 2025
1.3 years
February 17, 2024
August 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline in gastrointestinal symptom distress Scale at study day 5(end day)
The Gastrointestinal Symptom Distress Scale is a validated self-report tool that assesses 10 gastrointestinal symptoms that patients with esophageal cancer may face after surgery. The 10-question questionnaire measures the self-perceived severity of nausea, vomiting, satiety, bloating, abdominal cramps, acid reflux, chest tightness, heart burn, diarrhea, and constipation, as well as the degree of interference with life. Using an 11-point Likert scale, 0 points (never happened), 1 point (very slight/very slight interference), 10 points (very severe/extreme interference), and the total score of the scale is 0-100 points. The higher the measured score, the more severe the gastrointestinal discomfort symptoms are and the more they interfere with life. The Gastrointestinal Symptom Distress Scale was subjected to an expert validity review, using the CVI (content validity index) calculation method, and the score was above 0.80.
Baseline and study day 5
Study Arms (2)
acupressure
EXPERIMENTALParticipants received routine care and acupressure.
no intervision
NO INTERVENTIONreceived routine care
Interventions
In the experimental group, routine nursing care and acupressure (Neiguan and Zusanli points) were performed from the 1st to the 5th day after the postoperative transfer from the ward to the hospital room. Twice a day, 3 minutes each time, 12 minutes in total.
Eligibility Criteria
You may qualify if:
- Hospitalized men and women who agree to participate in this study
- Patients diagnosed with esophageal cancer based on pathological tissue section results
- Nutritional support through jejunostomy in post esophagectomy patients
- A sufficient level of education to understand study procedures and be able to communicate with site personnel
You may not qualify if:
- Pregnant or lactating women
- Diagnosed and treated for peripheral vascular disease within 3 months prior to surgery.
- Those with unstable vital signs and septicemia infection after surgery.
- Those who are suffering from blood diseases with abnormal coagulation function, or Currently taking anticoagulant drugs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CHEN, CHIA-CHENlead
Study Sites (1)
Chang Gung Memotial Hospital
Taoyuan District, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chia-Chen Chen
Chang Gung Memorail Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 17, 2024
First Posted
February 23, 2024
Study Start
March 27, 2024
Primary Completion
July 18, 2025
Study Completion
July 18, 2025
Last Updated
August 7, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share